Status:
COMPLETED
Role of Sympathetic Activation in Ischemia Reperfusion Injury
Lead Sponsor:
Royal Perth Hospital
Conditions:
Central Sympathetic Nervous System Diseases
Eligibility:
MALE
18-75 years
Phase:
PHASE4
Brief Summary
This study is designed to assess the effect of forearm ischemia-reperfusion injury on sympathetic nerve activity. To determine whether reduced sympathetic responsiveness is a contributor to the protec...
Detailed Description
This is a randomized single blind study where subjects will be allocated to undergo one of the 4 protocols. Participants will be given placebo or 0.2mg of Moxonidine to take orally 20 minutes prior to...
Eligibility Criteria
Inclusion
- healthy males, not on any medication, free of any history of metabolic, cardiovascular or cerebrovascular disease.
Exclusion
- smoker
Key Trial Info
Start Date :
July 8 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04479813
Start Date
July 8 2015
End Date
March 1 2022
Last Update
September 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dobney Hypertension Centre
Perth, Australia